Emerging biotech leader AKESF develops Ivonescimab & Cadonilimab; while offering growth potential with US partnerships, ...

More than 800 people in the U.S. have had measles since the beginning of the year, according to NBC News data. The majority ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Here's three main ways to type your blood: One of the easiest and most effective ways to determine your blood type is to have ...

Allergy medications not doing the job this season? Experts explain why allergy immunotherapy may be the newest answer to ...

The randomized control period of the MINT trial has completed, and these newest data describe outcomes among patients who ...

Introduction Limited data exist on brain MRI enhancement in myelin-oligodendrocyte-glycoprotein (MOG) antibody-associated disease (MOGAD) and differences from ...

The popular video app now has until mid-June to change its ownership structure, after President Trump extended its deadline twice. By Sapna Maheshwari TikTok isn’t going anywhere soon. The ...

In 2025, you'll pay more for Medicare with IRMAA brackets that start at $106,000 for individuals and $212,000 for couples. IRMAA (income-related monthly adjustment amount) is an extra fee that you pay ...

Research continues to elucidate the complex immunological processes underlying the pathophysiology of aquaporin 4-antibody seropositive (AQP4+) neuromyelitis optica spectrum disorder (NMOSD), ...

ImmunoPrecise Antibodies Ltd. (IPA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful ...